FRZB knockdown upregulates β-catenin activity and enhances cell aggressiveness in gastric cancer

Qin,Shuai; Zhang,Zhuo; Li,Jianfang; Zang,Lu

doi:10.3892/or.2014.3109

FRZB knockdown upregulates β-catenin activity and enhances cell aggressiveness in gastric cancer

Authors:
- Shuai Qin
- Zhuo Zhang
- Jianfang Li
- Lu Zang
View Affiliations

Affiliations: Department of Intensive Care Unit, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, P.R. China, Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, P.R. China, Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, P.R. China
Published online on: March 24, 2014 https://doi.org/10.3892/or.2014.3109
Pages: 2351-2357

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Studies have shown that FRZB correlates with gastric tumorigenicity and may play role in regulating the Wnt/β‑catenin signaling pathway. In the present study, we investigated the correlation between FRZB and the Wnt/β‑catenin signaling pathway using gastric cancer tissues and an FRZB‑knockdown gastric cancer cell line model. The protein levels of FRZB and β‑catenin were examined using immunohistochemical staining. FRZB-specific shRNAs were used to generate FRZB‑knockdown MKN45 gastric cancer cells. Cell proliferation assay, suspending culture and Annexin V/PI double staining analysis were used to investigate the role of FRZB knockdown in cell growth. In vitro migration/invasion assays were performed. The expression of Wnt/β‑catenin downstream targets was analyzed by RT-PCR. FRZB mRNA levels showed negative correlation with β‑catenin levels in paired non-tumor and tumor tissues. FRZB protein levels were negatively correlated with β‑catenin levels analyzed by IHC staining. Furthermore, high FRZB protein levels were correlated with membrane localization of β‑catenin. FRZB knockdown increased gastric cancer cell growth in monolayer and soft agar culture; it increased cell aggregates in suspending culture and rendered less apoptosis which indicated increased anti-anoikis growth. FRZB knockdown increased cell migration and invasion and increased the expression of Wnt/β‑catenin downstream targets such as MMP7 and cyclin D1. Our studies revealed that FRZB levels were correlated with β‑catenin subcellular localization. Knockdown of FRZB in gastric cancer cells increased cell growth and migration/invasion which was also accompanied by activation of Wnt/β‑catenin downstream targets. FRZB knockdown may upregulate the Wnt/β‑catenin pathway and promote aggressiveness in gastric cancer.

View Figures

View References

1	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
2	Yang L: Incidence and mortality of gastric cancer in China. World J Gastroenterol. 12:17–20. 2006.
3	Cho KH, Baek S and Sung MH: Wnt pathway mutations selected by optimal beta-catenin signaling for tumorigenesis. FEBS Lett. 580:3665–3670. 2006. View Article : Google Scholar : PubMed/NCBI
4	Thiery JP, Acloque H, Huang RY and Nieto MA: Epithelial-mesenchymal transitions in development and disease. Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
5	Hoang B, Moos M Jr, Vukicevic S and Luyten FP: Primary structure and tissue distribution of FRZB, a novel protein related to Drosophila frizzled, suggest a role in skeletal morphogenesis. J Biol Chem. 271:26131–26137. 1996. View Article : Google Scholar : PubMed/NCBI
6	Banyai L and Patthy L: The NTR module: domains of netrins, secreted frizzled related proteins and type I procollagen C-proteinase enhancer protein are homologous with tissue inhibitors of metalloproteases. Protein Sci. 8:1636–1642. 1999. View Article : Google Scholar
7	Killock D: Osteoarthritis: Frzb knockout reveals the complexity of Wnt signaling in joint homeostasis. Nat Rev Rheumatol. 8:1232012. View Article : Google Scholar : PubMed/NCBI
8	Lories RJ, Peeters J, Bakker A, et al: Articular cartilage and biomechanical properties of the long bones in Frzb-knockout mice. Arthritis Rheum. 56:4095–4103. 2007. View Article : Google Scholar : PubMed/NCBI
9	Kristensen IB, Haaber J, Lyng MB, et al: Myeloma plasma cell expression of osteoblast regulatory genes: overexpression of SFRP3 correlates with clinical bone involvement at diagnosis. Leuk Lymphoma. 54:425–427. 2013. View Article : Google Scholar : PubMed/NCBI
10	Mandal D, Srivastava A, Mahlum E, et al: Severe suppression of Frzb/sFRP3 transcription in osteogenic sarcoma. Gene. 386:131–138. 2007. View Article : Google Scholar : PubMed/NCBI
11	Qu Y, Li JF, Cai Q, et al: Over-expression of FRZB in gastric cancer cell suppresses proliferation and induces differentiation. J Cancer Res Clin Oncol. 134:353–364. 2008. View Article : Google Scholar : PubMed/NCBI
12	Zi X, Guo Y, Simoneau AR, et al: Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness. Cancer Res. 65:9762–9770. 2005. View Article : Google Scholar
13	Ekström EJ, Sherwood V and Andersson T: Methylation and loss of Secreted Frizzled-Related Protein 3 enhances melanoma cell migration and invasion. PLoS One. 6:e186742011.PubMed/NCBI
14	Guo Y, Xie J, Rubin E, et al: Frzb, a secreted Wnt antagonist, decreases growth and invasiveness of fibrosarcoma cells associated with inhibition of Met signaling. Cancer Res. 68:3350–3360. 2008. View Article : Google Scholar : PubMed/NCBI
15	Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ and Levin B: bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res. 55:237–241. 1995.PubMed/NCBI
16	Geiger TR, Song JY, Rosado A and Peeper DS: Functional characterization of human cancer-derived TRKB mutations. PLoS One. 6:e168712011. View Article : Google Scholar : PubMed/NCBI
17	Klein CA: Cancer. The metastasis cascade. Science. 321:1785–1787. 2008. View Article : Google Scholar : PubMed/NCBI
18	Kawano Y and Kypta R: Secreted antagonists of the Wnt signalling pathway. J Cell Sci. 116:2627–2634. 2003. View Article : Google Scholar : PubMed/NCBI
19	Zhao X, Huang H, Chen Y, et al: Dynamic expression of secreted Frizzled-related protein 3 (sFRP3) in the developing mouse spinal cord and dorsal root ganglia. Neuroscience. 248C:594–601. 2013. View Article : Google Scholar : PubMed/NCBI
20	Kristensen IB, Christensen JH, Lyng MB, et al: Expression of osteoblast and osteoclast regulatory genes in the bone marrow microenvironment in multiple myeloma: only upregulation of Wnt inhibitors SFRP3 and DKK1 is associated with lytic bone disease. Leuk Lymphoma. Aug 5–2013.(Epub ahead of print).
21	Kongkham PN, Northcott PA, Croul SE, Smith CA, Taylor MD and Rutka JT: The SFRP family of WNT inhibitors function as novel tumor suppressor genes epigenetically silenced in medulloblastoma. Oncogene. 29:3017–3024. 2010. View Article : Google Scholar : PubMed/NCBI
22	Nikuseva-Martic T, Serman L, Zeljko M, et al: Expression of secreted frizzled-related protein 1 and 3, T-cell factor 1 and lymphoid enhancer factor 1 in clear cell renal cell carcinoma. Pathol Oncol Res. 19:545–551. 2013. View Article : Google Scholar : PubMed/NCBI
23	Hirata H, Hinoda Y, Ueno K, Majid S, Saini S and Dahiya R: Role of secreted frizzled-related protein 3 in human renal cell carcinoma. Cancer Res. 70:1896–1905. 2010. View Article : Google Scholar : PubMed/NCBI
24	Lin DC, Zhang Y, Pan QJ, et al: PLK1 is transcriptionally activated by NF-κB during cell detachment and enhances anoikis resistance through inhibiting beta-catenin degradation in esophageal squamous cell carcinoma. Clin Cancer Res. 17:4285–4295. 2011.PubMed/NCBI
25	Fischer AN, Fuchs E, Mikula M, Huber H, Beug H and Mikulits W: PDGF essentially links TGF-beta signaling to nuclear beta-catenin accumulation in hepatocellular carcinoma progression. Oncogene. 26:3395–3405. 2007. View Article : Google Scholar : PubMed/NCBI